Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
CC-115 in newly diagnosed MGMT unmethylated glioblastoma in the individualized screening trial of innovative glioblastoma therapy (INSIGhT): a phase II randomized Bayesian adaptive platform trial
The Florey Institute of Neuroscience and Mental Health acknowledges support from the Victorian Government, in particular, funding from the Operational Infrastructure Support Grant
From inflammation to current and alternative therapies involved in wound healing
At four, it becomes more acute
US$ 28.67
:max_bytes(150000):strip_icc()/VWH-GettyImages-1305341722-b089448f8dc343378c30884a2128b5b9.jpg)
US$ 25.76
US$ 20.89
US$ 27.59
US$ 23.45
US$ 23.74
US$ 28495.00
Sold : Login>>